{ }
Very Negative
Negative
Neutral
Positive
Very Positive
2025-03-272025-03-272025-04-012025-04-012133221100
Download SVG
Download PNG
Download CSV
Somewhat Relevant
Moderately Relevant
Very Relevant
Highly Relevant
2025-03-272025-03-272025-04-012025-04-012133221100
Download SVG
Download PNG
Download CSV

UBS Maintains Neutral Rating on Salesforce with Price Target of 360 Dollars

UBS has maintained a "Neutral" rating on Salesforce, setting a price target of $360. Analyst Karl Keirstead noted that the software group's quarterly results and outlook for the final quarter were mixed, although a competitor in the SAP industry appeared more optimistic about demand trends.
14:59 04.12.2024

UBS Maintains Buy Rating for SAP SE with Target Price of 237 Euros

UBS AG has maintained a "Buy" rating for SAP SE shares, setting a target price of 237 euros. Analyst Michael Briest expressed confidence in the company's growth acceleration following discussions at a recent technology and AI event. SAP shares rose 1.7% to 236.95 euros, reflecting a 72% increase since the start of 2024, with Q4 2024 financial results expected on January 28, 2025.
14:52 04.12.2024

UBS Maintains Buy Rating for SAP with Target Price of 237 Euros

UBS has maintained its "Buy" rating for SAP, setting a target price of 237 euros. Analyst Michael Briest expressed continued confidence in the company's growth acceleration following discussions with the CFO at a UBS technology and AI event.
12:02 04.12.2024

SAP SE Dominates Global Software Market with Strong Sales Performance

SAP SE, a global leader in integrated software solutions, generates 86.3% of its revenue from software sales, including financial and human resources management. The company’s sales are geographically distributed with 32.7% from the United States, followed by Europe-Middle East-Africa at 29.1%.
11:53 04.12.2024

UBS Maintains Buy Rating for SAP with Target Price of 237 Euros

UBS has maintained its 'Buy' rating for SAP, setting a target price of 237 euros. Analyst Michael Briest expressed continued confidence in the company's growth prospects following discussions with the CFO at a recent UBS technology and AI event. As of the latest trading, SAP shares are showing a positive trend, with prices around €241.60, reflecting a gain of over 4%.
11:02 04.12.2024

UBS Maintains Buy Rating for SAP SE with Target Price of 237 Euros

UBS AG has maintained its "Buy" rating for SAP SE, setting a target price of 237 euros, following insights from an interview with the CFO at a recent technology and AI event. As of 11:36 a.m., SAP's share price increased by 1.7% to EUR 236.95, reflecting a 72% rise since the start of 2024. The company is set to announce its Q4 2024 results on January 28, 2025.
08:08 04.12.2024

customized market research solutions for strategic business success and growth

Customized market analysis services offer clients tailored insights to navigate market opportunities and challenges effectively. With options for 20% customization, the ability to select five countries and companies, and 40 hours of free customization, clients receive comprehensive support, including one year of after-sales assistance. The reports provide in-depth analysis of market segments, trends, and competitive landscapes, empowering stakeholders to make informed decisions.

healthcare crm market projected to grow at 7.7 percent through 2031

The global Healthcare CRM market is projected to grow from USD 17.87 billion in 2023 at a CAGR of 7.7% through 2031, driven by increasing demand for structured data and automation in healthcare. Key players include Microsoft, Oracle, and Salesforce, with a focus on enhancing consumer engagement through advanced technologies. The market analysis covers various segments and regions, identifying growth opportunities and competitive dynamics.

growth of internet of things in healthcare market projected to soar

The Internet of Things (IoT) in Healthcare market is projected to grow from USD 53.65 billion in 2023 to USD 206.10 billion by 2032, driven by factors such as the aging population, rising chronic diseases, and advancements in AI and telemedicine. Key trends include the adoption of blockchain for data security and remote patient monitoring, while challenges like data privacy concerns and high implementation costs persist. Major players in the market include Medtronic, IBM, and Microsoft, highlighting a competitive landscape focused on enhancing patient care through connected devices.

economic outlook for 2025 challenges for equities and gold prices

Inflation expectations are likely to decline, potentially impacting gold prices, while US equities face a challenging year ahead, particularly in 2025. The Russell 2000 small-cap index shows promise, and falling interest rates in Europe may strengthen the dollar, benefiting European stocks. However, Trump's tariffs pose significant risks for non-US markets, and the new Treasury Secretary's focus on reducing the deficit and increasing oil production could further dampen inflation expectations.
Trending
Subcategory
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.